Funding
April 9, 2012
|
April 9, 2012
|
April 9, 2012
|
March 6, 2012
|
Key Documents
Letters, Testimony & Comments
March 16 2012
Dear Majority Leader Reid and Minority Leader McConnell:
On behalf of the Biotechnology Industry Organization (BIO) and its more than 1...
March 6 2012
William D. Waddill, Senior Vice President and Chief Financial Officer OncoMed Pharmaceuticals highlights the importance of capital...
December 1 2011
On December 1, BIO submitted written testimony to the Senate Committee on Banking, Housing, and Urban Affairs on the importance of...
May 17 2011
Dear Chairman Frelinghuysen and Ranking Member Visclosky:
On behalf of the Biotechnology Industry Organization (BIO), I am writing to...
BIO Requests for FY 2012 Agriculture, Rural Development, FDA and Related Agencies Appropriations Act
May 12 2011
Dear Chairman Kingston and Ranking Member Farr:
On behalf of the Biotechnology Industry Organization (BIO), I am writing to encourage...
Press Releases
December 6 2011
Washington, DC (December 6, 2011) – The Biotechnology Industry Organization (BIO) announces program topics...
November 16 2011
Self-Funding Program Supported by Leading Biotech Trade Associations
WASHINGTON, D.C. (November 16, 2011)...
November 2 2011
Washington, DC (November 2, 2011) – The Biotechnology Industry Organization (BIO) strongly supports the Small...
October 13 2011
Washington, D.C. (October 13, 2011) – Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood...
September 16 2011
Washington, D.C. (September 16, 2011) – Biotechnology Industry Organization (BIO) President and CEO Jim...
Receive our newsletter from BIOtechNow
Business Solutions Sponsor
